HUMAN Gesellschaft fuer Biochemica und Diagnostica mbH  

Max-Planck-Ring 21
Wiesbaden,  65205

Germany
https://www.human.de

• Booth: 921

HUMAN has been one of the global players in the IVD industry for more than 50 years. Its broad and steadily growing portfolio ranges from classical clinical chemistry to innovative molecular diagnostic methods as well as special applications like assays for autoimmunity testing. With its global service and logistics capacities and a broad network of long-standing distributors, HUMAN supports medical laboratories worldwide and is a recognized partner to numerous governmental and non-governmental organizations. Local HUMAN representatives are based in over 160 countries around the world. Our products are developed in Germany using German quality standards and are specifically geared towards the needs of laboratories in less developed countries. Sustainability is a particular concern for HUMAN as a responsible and future-oriented company. Our certified environmental management system meets the requirements of the international ISO 14001 standard and the European EMAS directive.

 Videos

 Press Releases

• HUMAN celebrates its 50th anniversary (Jun 05, 2023)
  • From reagent specialist to global player with a broad network of long-standing distribution partners in more than 160 countries
  • Covering a comprehensive product portfolio with more than 400 in-vitro diagnostic products in 12 segments

  Wiesbaden, Germany, June 05, 2022 – Since its foundation in 1972, HUMAN Gesellschaft für Biochemica und Diagnostica mbH has been developing and marketing comprehensive solutions for in vitro diagnostics (IVD). The portfolio ranges from classical clinical chemistry to innovative molecular diagnostic methods as well as special applications such as assays for autoimmunity testing.

  The German medium-sized company has its headquarters in Wiesbaden (close to Frankfurt) and its development and production site in Magdeburg. In addition, HUMAN maintains regional sales offices in Singapore, China, India, United Arab Emirates, Panama and has local HUMAN representatives in many other countries.

  With its approximately 300 employees from over 40 nations, its worldwide service and delivery capacities, and a broad network of long-standing sales partners, HUMAN supports medical laboratories in more than 160 countries.

  "HUMAN has grown from a small reagent manufacturer to a global player in in vitro diagnostics," says Dr. Björn Breth, CEO of HUMAN since 2019. "For 50 years now, we have been helping to improve healthcare in many places around the world. With our comprehensive portfolio, we cover a wide range of regional needs, from semi-automated devices to fully automated solutions. Through our logistics and services, we are a recognized partner to numerous governmental and non-governmental organizations (NGOs) in support of medical care, particularly in crisis areas.  We remain committed to Germany as a business location, where we develop and produce the majority of products (reagents)."

  At the development and production site in Magdeburg scientists work with modern technologies on further developments and innovations with a focus on clinical chemistry, hematology, hemostasis, and immunoassays and in compliance with the highest European quality standards.

  Sustainability is a particular concern for HUMAN as a responsible and future-oriented company. A certified environmental management system has been established that meets the requirements of the international ISO 14001 standard and the European EMAS directive.  In addition, a resource-efficient orientation is increasingly taking place in terms of energy generation: at its headquarters, for example, HUMAN already covers over 86% of its annual requirements through renewable energy.

  Interesting facts about the 50-year history of HUMAN, milestones and product highlights as well as voices and insights of the cooperation partners can be found on its anniversary page.

  CONTACT PERSON

  Thomas König

  Sr. Manager Marketing Communication & PR

  E-mail: t.koenig@human.de

  Phone: +49 6122 9988 167

  Web: www.human.de

• HumaFIA – Accurate results on-the-spot (Jun 05, 2023)

  > Very high sensitivity due to time-resolved fluorescence immunoassay technology

  > Workflow management for multi-throughput

  > One platform for a large range of parameters

  Wiesbaden, Germany, June 05, 2022 – On-the-spot testing solutions require easy-to-use devices, preferably working with whole blood, that provide results within minutes. This is needed in emergency centers in cases of chest pain or cardiac distress, but also in physicans’ offices or hospital wards, and especially in remote areas for patients with long travel distances who need the diagnosis on the day of their visit.

  With the HumaFIA, HUMAN’s new addition to the immunoassay product line, a wide range of tests for early detection of critical diseases can be performed on a single platform. It is easy-to-use, for rapid, accurate results on the spot:

  • Auto quality check with incubation monitoring and LOT verification – assuring high quality results

  • Work-flow management, allows to run a test to be run every 20 seconds – saves you time during peak hours

  • Auto pre-dilution calculation to extend the measuring range – enables correct result documentation

  • Easy testing by using whole blood, serum and plasma – increases your flexibility

  Visit the HumaFIA product page

  Download product flyer

• HumaCount 5DCRP – The 2-in-1 solution – 5-part diff and C-Reactive Protein (Jun 05, 2023)

  > Distinct 5-part diff

  > Immunoturbidimetric detection of CRP

  > Direct capillary blood process with OptimalCount Technology

  Wiesbaden, Germany, June 05, 2022 – CRP has a fast kinetic and the levels in the blood increase rapidly when a condition causes inflammation. Together with clinical signs, CRP in combination with WBC-differentiation helps distinguish between viral and bacterial infections and avoid the overuse of antibiotics.

  C-reactive protein whole blood tests must be calibrated so that whole blood CRP levels correlate with the corresponding serum/plasma level to avoid false results in the presence of abnormal hematocrit levels. The integrated reagent cooling system guarantees maximum efficiency of the workflow, as the reagent flask with CRP antibodies can remain connected to the instrument during the entire open vial stability time.

  The reduction in numbers of microscopy is the driving force in hematology. New parameters provided by the  HumaCount 5DCRP like Large Immature Cells (LIC) and atypical Lymphocytes (ALY) help to reduce the manual workload by focusing on the confirmation of abnormal cells. The 3D-laser-scatter technology guarantees an excellent 5- part differentiation as required by clinicians. The ability to work with both venous and capillary blood samples, make the HumaCount 5DCRP a well-rounded instrument. The compact size and high throughput support the placement in both small and medium sized labs.

  • Parallel detection of 5-part diff and CRP in a whole blood sample
  • Direct capillary blood process by OptimalCount Technology
  • Throughput: up to 60 samples per hour
  • Sample volume: 20 μl
  • 32 parameters with CRP
  • 3D laser detection for improved 5-part differentiation
  • Flexibility through a wide range of testing options (5-part, CRP and CBC)
  • 2D barcode target value transfer

  Visit the product page

  Download product flyer

• HumaNex A1c Variant – HPLC system for small and medium-scale measurement of glycated hemoglobin HbA1c (Jun 05, 2023)

  > HPLC technology - the gold standard of HbA1c testing

  > Outstanding analytical performance - Hb-variants detection

  > NGSP and IFCC certified

  Wiesbaden, Germany, June 05, 2022 – HbA1c refers to glycated hemoglobin. It develops when hemoglobin joins with glucose in the blood, becoming 'glycated'. In contrast to direct glucose, the HbA1c parameter provides an average of the patient's blood sugar levels over a period of 2 - 3 months. It is therefore not affected by daily fluctuations. HbA1c is recommended by the American Diabetes Association (ADA) for monitoring how well the patient’s diabetes treatment is working over time and to diagnose diabetes using a NGSP-certified method with a cutoff of HbA1c ≥ 6.5%.

  Research has also shown that people with type 2 diabetes who reduce their HbA1c level by 1% are:

  > 19% less likely to suffer cataracts

  > 16% less likely to suffer heart failure

  > 43% less likely to suffer amputation or death due to peripheral vascular disease

  Detect variants, provide more insights

  In contrast to other methods, HUMAN’s HumaNex A1c Variant will give you the details that enable you to provide the full picture to your physicians. Detected variants are visible on the chromatogram and considered when calculating the HbA1c result to reduce interferences. While HbE, HbD, HbS and HbC variants are the most common Hb variants, there are 1000s more rare pathological Hb variants. "HbA1c only“ HPLC analyzers or immunological HbA1c tests cannot detect these variants. This creates a blind spot for the physician because some variants can also reduce or prolong the typical RBC lifespan and therefore require extra caution when interpreting HbA1c results. Knowing of the existence of these variants is important for many physicians.

  The HumaNex A1c Variant is the newest addition to HUMAN’s offering for HbA1c testing and is suited great for small to medium HbA1c volumes while adding the advantage of variant detection. It is part of HUMAN's diabetes care portfolio, which is unique in its comprehensiveness covering primary diagnosis, compliance monitoring and daily (self) glucose measuring.

  • Gold standard HPLC technology
  • Ultra-sharp chromatographic resolution
  • HbA1c result in 130 sec
  • Detect common Hb variants (HbE, HbS, HbC, HbD)
  • Measuring range 3 % to 18 % NGSP
  • Less than 1.2 % CV
  • Intuitive, touch-controlled software
  • Fully automated with an onboard capacity of 10 samples
  • Sample identification via external barcode reader
  • Sample volume: 5 μl diluent mode / 1.5 ml whole blood mode
  • Cap piercing

  Visit product page

  Download product flyer

 Additional Info